1. American Heartworm Society, 1993. Recommended procedures for the diagnosis and management of heartworm (Dirofilaria immitis) infection. In: Soll, M.D. (Ed.), Proceedings of the Heartworm Symposium ’92, American Heartworm Society, Batavia, IL, pp. 289–294.
2. Blagburn, B.L., Hendrix, C.M., Lindsay, D.S., Vaughan, J.L., Hepler, D.I., 1993. Post-adulticide milbemycin oxime microfilaricidal activity in dogs naturally infected with Dirofilaria immitis. In: Soll, M.D. (Ed.), Proceedings of the Heartworm Symposium ’92, American Heartworm Society, Batavia, IL, pp. 159–164.
3. Adverse drug reactions in the treatment of filarial parasites: haematological, biochemical, immunological and pharmacological changes in Dirofilaria immitis infected dogs treated with diethylcarbamazine;Boreham;Int. J. Parasitol.,1983
4. Courtney, C.H., Zeng, Q.-Y., 1989. The structure of heartworm populations in dogstpandtpcats in Florida. In: Otto, G.F. (Ed.), Proceedings of the Heartworm Symposium ’89, American Heartworm Society, Washington, DC, pp. 1–6.
5. Courtney, C.H., Zeng, Q.-Y., Maler, M.M., 1999. The effect of chronic administration of milbemycin oxime and ivermectin on microfilaremias in heartworm-infected dogs. In: Seward, R.L., Knight, D.H. (Eds.), Proceedings of the Recent Advances in Heartworm Disease: Symposium ’98, American Heartworm Society, Batavia, IL, pp. 193–199.